Change of Advisers

Futura Medical PLC
28 February 2005




RNS Release                                                     28 February 2005



               Futura Medical change in Nominated Adviser and Broker


Futura Medical plc ('Futura'), the AIM-quoted pharmaceutical drug and medical
device group that develops innovative products for the sexual healthcare market,
announces the following adviser appointments with immediate effect:



Nominated Adviser
Canaccord Capital (Europe) Limited


Joint brokers
Collins Stewart Limited


Canaccord Capital (Europe) Limited remains joint broker.


For further information:
Futura Medical plc
James Barder, Chief Executive                          Tel: [phone]

Canaccord Capital (Europe) Ltd
Stephen Rowntree                                       Tel: [phone]

Collins Stewart Ltd
Chris Howard                                           Tel: + 44 (0) 20 7523 8350


Media enquiries:
Abchurch
Peter Curtain / Alex Tweed                             Tel: [phone]
mailto: [e-mail]                  www.abchurch-group.com


www.futuramedical.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange                DGGUI